Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?

Tomljenovic L, Spinosa JP, Shaw CA.

Curr Pharm Des. 2013;19(8):1466-87. Review.

PMID:
23016780
[PubMed - indexed for MEDLINE]
2.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

PMID:
17380109
[PubMed - indexed for MEDLINE]
Free Article
3.

Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics.

Pomfret TC, Gagnon JM Jr, Gilchrist AT.

J Clin Pharm Ther. 2011 Feb;36(1):1-9. doi: 10.1111/j.1365-2710.2009.01150.x. Review.

PMID:
21198715
[PubMed - indexed for MEDLINE]
4.

Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.

Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA.

Pharmacotherapy. 2011 Mar;31(3):280-97. doi: 10.1592/phco.31.3.280. Review.

PMID:
21361739
[PubMed - indexed for MEDLINE]
5.

Human papillomavirus vaccine: widening the scope for cancer prevention.

No JH, Kim MK, Jeon YT, Kim YB, Song YS.

Mol Carcinog. 2011 Apr;50(4):244-53. doi: 10.1002/mc.20657. Review.

PMID:
21465574
[PubMed - indexed for MEDLINE]
6.
7.

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Rambout L, Hopkins L, Hutton B, Fergusson D.

CMAJ. 2007 Aug 28;177(5):469-79. Epub 2007 Aug 1. Review.

PMID:
17671238
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.

J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.

PMID:
20139221
[PubMed - indexed for MEDLINE]
Free Article
9.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.

J Natl Cancer Inst. 2009 Apr 1;101(7):475-87. doi: 10.1093/jnci/djn510. Epub 2009 Mar 24.

PMID:
19318628
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cervical cancers after human papillomavirus vaccination.

Beller U, Abu-Rustum NR.

Obstet Gynecol. 2009 Feb;113(2 Pt 2):550-2. doi: 10.1097/AOG.0b013e318191a54a.

PMID:
19155953
[PubMed - indexed for MEDLINE]
11.

Quadrivalent human papillomavirus vaccine.

Barr E, Tamms G.

Clin Infect Dis. 2007 Sep 1;45(5):609-7. Epub 2007 Jul 25. Review.

PMID:
17682997
[PubMed - indexed for MEDLINE]
Free Article
12.

[What should be known for the introduction of an HPV vaccine?].

Muñoz N, Jacquard AC.

Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10. Review. French.

PMID:
18786806
[PubMed - indexed for MEDLINE]
13.

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.

Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A.

Lancet. 2009 Jun 6;373(9679):1949-57. doi: 10.1016/S0140-6736(09)60691-7. Epub 2009 Jun 1.

PMID:
19493565
[PubMed - indexed for MEDLINE]
14.

Post-licensure monitoring of HPV vaccine in the United States.

Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF.

Vaccine. 2010 Jul 5;28(30):4731-7. doi: 10.1016/j.vaccine.2010.02.019. Epub 2010 Feb 25. Review.

PMID:
20188681
[PubMed - indexed for MEDLINE]
15.

Human papillomavirus vaccines.

Satyaprakash A, Creed R, Ravanfar P, Mendoza N.

Dermatol Ther. 2009 Mar-Apr;22(2):150-7. doi: 10.1111/j.1529-8019.2009.01227.x. Review.

PMID:
19335726
[PubMed - indexed for MEDLINE]
16.

Safety of human papillomavirus vaccines: a review.

Macartney KK, Chiu C, Georgousakis M, Brotherton JM.

Drug Saf. 2013 Jun;36(6):393-412. doi: 10.1007/s40264-013-0039-5. Review.

PMID:
23637071
[PubMed - indexed for MEDLINE]
17.

HPV vaccine: Cervarix.

Szarewski A.

Expert Opin Biol Ther. 2010 Mar;10(3):477-87. doi: 10.1517/14712591003601944. Review.

PMID:
20132062
[PubMed - indexed for MEDLINE]
18.

Currently approved prophylactic HPV vaccines.

Harper DM.

Expert Rev Vaccines. 2009 Dec;8(12):1663-79. doi: 10.1586/erv.09.123. Review.

PMID:
19943762
[PubMed - indexed for MEDLINE]
19.

Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles.

Capri S, Gasparini R, Panatto D, Demarteau N.

Gynecol Oncol. 2011 Jun 1;121(3):514-21. doi: 10.1016/j.ygyno.2011.01.029. Epub 2011 Feb 19.

PMID:
21334734
[PubMed - indexed for MEDLINE]
20.

Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.

McIntosh J, Sturpe DA, Khanna N.

J Am Pharm Assoc (2003). 2008 Jan-Feb;48(1):e1-13; quiz e14-7. doi: 10.1331/JAPhA/2008.07032. Review.

PMID:
18192123
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk